haven 6: emicizumab prophylaxis in non-severe hemophilia a without fviii inhibitors
Published 2 years ago • 338 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
2:49
haven-6 trial updates: emicizumab in non-severe hemophilia a
-
6:11
haven 7: emicizumab prophylaxis for the treatment of infants with severe hemophilia a
-
1:09
low-dose emicizumab prophylaxis in patients with severe hemophilia a
-
2:15
emicizumab prophylaxis instead of immunosuppressive therapy in patients with acquired hemophilia a
-
8:37
primary analysis of haven 7: emicizumab prophylaxis in infants with severe hemophilia a
-
2:06
emicizumab prophylaxis in hemophilia a
-
4:01
emicizumab for hemophilia a: interim analysis of the real-world emiil study
-
4:36
haemonetics
-
27:32
chapter 7: treatment of specific hemorrhages
-
10:09
prophylaxis in hemophilia: past, present and future
-
1:23
the present and future of hemophilia a treatment
-
1:36
unmet needs in hemophilia: guidelines for emicizumab & better therapeutics for hemophilia a
-
2:47
real-world data on the safety of emicizumab in patients with hemophilia a
-
1:43
the impact of emicizumab prophylaxis on caregivers' burden for patients with hemophilia a
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
-
1:05
promising antibodies being explored in hemophilia & a novel diagnostic tool for patients
-
1:27
the impact of emicizumab on the hemophilia treatment landscape
-
1:18
unmet needs in hemophilia treatment
-
1:58
how hemophilia care has changed over the years
-
3:45
how emicizumab has changed hemophilia a management
-
14:38
chapter 6: prophylaxis in hemophilia